E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/7/2005 in the Prospect News Biotech Daily.

LabCorp board approves $500 million stock repurchase program, to buy $250 million immediately

By E. Janene Geiss

Philadelphia, Dec. 7 - Laboratory Corp. of America Holdings said Wednesday that its board authorized a $500 million share repurchase program.

The company said it plans to repurchase about 4.8 million shares of the company's common stock for $250 million under an overnight agreement providing for the immediate purchase of the shares.

The repurchase will be financed through borrowings under LabCorp's senior credit facility.

The new program is in addition to LabCorp's previously announced stock repurchase program.

Company officials that the repurchase is consistent with its goal of making investments with the company's cash resources that enhance shareholder value.

LabCorp, based in Burlington, N.C., is the second largest independent laboratory company in the United States based on 2004 net revenues.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.